These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 16469684

  • 21. Prevalence of nonalcoholic fatty liver disease (NAFLD) and utility of FIBROspect II to detect liver fibrosis in morbidly obese Hispano-American patients undergoing gastric bypass.
    Guajardo-Salinas GE, Hilmy A.
    Obes Surg; 2010 Dec; 20(12):1647-53. PubMed ID: 19957049
    [Abstract] [Full Text] [Related]

  • 22. IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients.
    García-Galiano D, Sánchez-Garrido MA, Espejo I, Montero JL, Costán G, Marchal T, Membrives A, Gallardo-Valverde JM, Muñoz-Castañeda JR, Arévalo E, De la Mata M, Muntané J.
    Obes Surg; 2007 Apr; 17(4):493-503. PubMed ID: 17608262
    [Abstract] [Full Text] [Related]

  • 23. Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
    Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ, Nonalcoholic Steatohepatitis Clinical Research Network.
    Hepatology; 2005 Jun; 41(6):1313-21. PubMed ID: 15915461
    [Abstract] [Full Text] [Related]

  • 24. Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease.
    Ma H, Gomez V, Lu L, Yang X, Wu X, Xiao SY.
    J Gastroenterol Hepatol; 2009 Feb; 24(2):233-7. PubMed ID: 18713296
    [Abstract] [Full Text] [Related]

  • 25. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
    Garg H, Aggarwal S, Shalimar, Yadav R, Datta Gupta S, Agarwal L, Agarwal S.
    Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
    [Abstract] [Full Text] [Related]

  • 26. Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis.
    Hohenester S, Christiansen S, Nagel J, Wimmer R, Artmann R, Denk G, Bischoff M, Bischoff G, Rust C.
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep 01; 315(3):G329-G338. PubMed ID: 29878845
    [Abstract] [Full Text] [Related]

  • 27. Non-alcoholic steatohepatitis in children.
    Nanda K.
    Pediatr Transplant; 2004 Dec 01; 8(6):613-8. PubMed ID: 15598336
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Clinical and histological features of non-alcoholic fatty liver disease].
    Shi JP, Xun YH, Hu CB, Zhang L, Liu H, Lou GQ, Fan JG.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov 01; 17(11):812-6. PubMed ID: 19958638
    [Abstract] [Full Text] [Related]

  • 30. Clinical and histological features of nonalcoholic fatty liver disease in children.
    Ko JS, Yoon JM, Yang HR, Myung JK, Kim H, Kang GH, Cheon JE, Seo JK.
    Dig Dis Sci; 2009 Oct 01; 54(10):2225-30. PubMed ID: 19697129
    [Abstract] [Full Text] [Related]

  • 31. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.
    Leite NC, Villela-Nogueira CA, Pannain VL, Bottino AC, Rezende GF, Cardoso CR, Salles GF.
    Liver Int; 2011 May 01; 31(5):700-6. PubMed ID: 21457442
    [Abstract] [Full Text] [Related]

  • 32. Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease.
    Patton HM, Yates K, Unalp-Arida A, Behling CA, Huang TT, Rosenthal P, Sanyal AJ, Schwimmer JB, Lavine JE.
    Am J Gastroenterol; 2010 Sep 01; 105(9):2093-102. PubMed ID: 20372110
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery.
    Beymer C, Kowdley KV, Larson A, Edmonson P, Dellinger EP, Flum DR.
    Arch Surg; 2003 Nov 01; 138(11):1240-4. PubMed ID: 14609874
    [Abstract] [Full Text] [Related]

  • 36. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
    Chavarría-Arciniega S, López-Alvarenga JC, Uribe-Uribe NO, Herrera-Hernández M, González-Barranco J.
    Rev Invest Clin; 2005 Nov 01; 57(4):505-12. PubMed ID: 16315634
    [Abstract] [Full Text] [Related]

  • 37. Lipid peroxidation in bariatric candidates with nonalcoholic fatty liver disease (NAFLD) -- preliminary findings.
    Oliveira CP, Faintuch J, Rascovski A, Furuya CK, Bastos Mdo S, Matsuda M, Della Nina BI, Yahnosi K, Abdala DS, Vezozzo DC, Alves VA, Zilberstein B, Garrido AB, Halpern A, Carrilho FJ, Gama-Rodrigues JJ.
    Obes Surg; 2005 Apr 01; 15(4):502-5. PubMed ID: 15946429
    [Abstract] [Full Text] [Related]

  • 38. Prevalence and predictors of nonalcoholic steatohepatitis in obese patients undergoing bariatric surgery: a Department of Defense experience.
    Reha JL, Lee S, Hofmann LJ.
    Am Surg; 2014 Jun 01; 80(6):595-9. PubMed ID: 24887798
    [Abstract] [Full Text] [Related]

  • 39. Resolution of nonalcoholic steatohepatits after gastric bypass surgery.
    Liu X, Lazenby AJ, Clements RH, Jhala N, Abrams GA.
    Obes Surg; 2007 Apr 01; 17(4):486-92. PubMed ID: 17608261
    [Abstract] [Full Text] [Related]

  • 40. Histopathology of pediatric nonalcoholic fatty liver disease.
    Schwimmer JB, Behling C, Newbury R, Deutsch R, Nievergelt C, Schork NJ, Lavine JE.
    Hepatology; 2005 Sep 01; 42(3):641-9. PubMed ID: 16116629
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.